Literature DB >> 10869882

Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine.

D Hinze-Selch1, A Schuld, T Kraus, M Kühn, M Uhr, M Haack, T Pollmächer.   

Abstract

Leptin, tumor necrosis factor-alpha (TNF-alpha), and soluble TNF receptors are involved in weight regulation. Antipsychotic agents, such as clozapine, induce weight gain and increase circulating levels of these cytokines. To assess whether obesity-inducing antidepressants have a similar effect, we measured plasma cytokine levels in depressive inpatients during the first six weeks of treatment with tricyclic agents (amitriptyline or nortriptyline, n = 12), with paroxetine (n = 10), or without medication (n = 14). There was an increase in the body mass index at week 6 of treatment with the tricyclics, which was preceded by a significant increase in soluble TNF receptor p75 plasma levels. Circulating levels of leptin were not affected. Paroxetine and drug-free treatment did not affect any of these parameters. We conclude that weight gain induced by psychotropic agents may occur without increased circulating levels of leptin. However, activation of the TNF-alpha system might be an early and sensitive marker of ensuing weight gain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10869882     DOI: 10.1016/S0893-133X(00)00089-0

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  29 in total

Review 1.  Pharmacogenetics of antipsychotic-induced weight gain.

Authors:  Christoph U Correll; Anil K Malhotra
Journal:  Psychopharmacology (Berl)       Date:  2004-07-08       Impact factor: 4.530

Review 2.  The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications.

Authors:  Roger S McIntyre; Ka Young Park; Candy W Y Law; Farah Sultan; Amanda Adams; Maria Teresa Lourenco; Aaron K S Lo; Joanna K Soczynska; Hanna Woldeyohannes; Mohammad Alsuwaidan; Jinju Yoon; Sidney H Kennedy
Journal:  CNS Drugs       Date:  2010-09       Impact factor: 5.749

Review 3.  Antidepressant use in ambulatory cancer patients.

Authors:  H Florence Kim; Michael J Fisch
Journal:  Curr Oncol Rep       Date:  2006-07       Impact factor: 5.075

Review 4.  Inflammatory cytokine-associated depression.

Authors:  Francis E Lotrich
Journal:  Brain Res       Date:  2014-07-05       Impact factor: 3.252

5.  Psychiatric aspects of toxoplasmosis: an Indian perspective.

Authors:  Ajish G Mangot
Journal:  J Parasit Dis       Date:  2015-05-15

6.  Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males.

Authors:  Yi-Chyan Chen; Wei-Win Lin; Yu-Jung Chen; Wei-Chung Mao; Yi-Jen Hung
Journal:  Mediators Inflamm       Date:  2010-05-18       Impact factor: 4.711

7.  To assess, to control, to exclude: effects of biobehavioral factors on circulating inflammatory markers.

Authors:  Mary-Frances O'Connor; Julie E Bower; Hyong Jin Cho; J David Creswell; Stoyan Dimitrov; Mary E Hamby; Michael A Hoyt; Jennifer L Martin; Theodore F Robles; Erica K Sloan; Kamala S Thomas; Michael R Irwin
Journal:  Brain Behav Immun       Date:  2009-04-21       Impact factor: 7.217

8.  Stress and body mass index each contributes independently to tumor necrosis factor-alpha production in prepubescent Latino children.

Authors:  Denise Dixon; Hongdao Meng; Ronald Goldberg; Neil Schneiderman; Alan Delamater
Journal:  J Pediatr Nurs       Date:  2008-09-04       Impact factor: 2.145

Review 9.  Preventive treatment of migraine: effect on weight.

Authors:  William B Young
Journal:  Curr Pain Headache Rep       Date:  2008-06

Review 10.  [Atypical antipsychotics and metabolic syndrome].

Authors:  Andreas Baranyi; Renè Yazdani; Alexandra Haas-Krammer; Alexandra Stepan; Hans-Peter Kapfhammer; Hans-Bernd Rothenhäusler
Journal:  Wien Med Wochenschr       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.